HEG Limited (HEG) Earnings Call Transcript & Summary

February 14, 2020

National Stock Exchange of India IN Industrials Electrical Equipment earnings 31 min

Earnings Call Speaker Segments

Operator

operator
#1

Ladies and gentlemen, good afternoon, and welcome to the HEG Limited conference call to discuss the company's Q3 FY '20 results. Joining on the call today is Mr. Manish Gulati, COO and CMO, HEG Limited; Mr. Gulshan Sakhuja, CFO, HEG Limited; and Mr. Om Prakash Ajmera, Group CFO, HEG Limited. [Operator Instructions] Please note that this conference is being recorded. At this time, I would like to hand over the floor to Mr. Manish Gulati. Thank you, and over to you.

Manish Gulati

executive
#2

Good afternoon, friends, and welcome to our Q3 FY '19, '20 con call. This is Manish Gulati, and I just wanted to share with you that I've been appointed as Executive Director of the company with effect from 1st of March 2020. So in the year 2019, total world crude steel production registered a growth of 3.4%, which came mainly on the back of a high 8.3% growth coming from China. But if you look at the steel production in the rest of the world, without China, after 2 years of positive growth, it was minus 1.7% last year. Now China, which produced 50% of the total world's steel in 2016, has been continuously growing in production and today, they now produce 53% of all steel made in the world. The Electric Arc Furnace steel production was down in some of the large steel producing regions, like Europe, Japan, U.S., Turkey, mainly resulting from a slowdown in demand, the trade tensions between U.S. and China and other geopolitical tensions in some parts of the world. Iran steel production, which is mainly EAF-based grew in 2019 by 30%, but due to sanctions, we could not participate in this growth. Due to reduced demand of electrodes and large inventory overhang, which was caused due to customers buying much higher volumes of electrodes in 2018 and in the first few months of 2019, on account of the unprecedented increase in electrode prices month after month, we have seen much less buying in the last couple of quarters. As you're all aware, graphite electrodes has a long production cycle, anywhere between 6 to 8 weeks, to 20 to 24 weeks for different category of electrodes and nipples that we produce. Moreover, as our primary raw material Needle coke is totally imported by us from Europe, U.S. and Japan, at any particular time, we have a large inventory of Needle coke in stock on seaborne transit and work in process, given the above stated production cycle. And finally, in the form of finished electrodes. While the electrode prices have corrected in the past few quarters, we are -- we still keep consuming high-priced coke. Since the past year, the electrode prices have been sequentially dropping quarter after quarter to reflect the market conditions. As the customer has overbought in 2018 and first half of 2019, the new purchases have come down to more normal operating levels. This has led to a drop in our revenue and EBITDA margins, et cetera. However, one of the largest industries there, from Japan, has recently announced a shutdown of one of its plant impacting a reduction of 40,000 tons of electrode capacity and is further considering temporary idling of another 25,000 to 27,000 ton capacity in Europe. This should help in stabilizing the market. On our side, we are vigorously pursuing our expansion, which is going as per original schedule, and as planned, it should be operational in quarter of 2022. Our plant with an installed capacity of 80,000 tons is currently the single largest plant in the world. And by addition of another 20,000 tons, it would become even larger, giving us significant advantage in cost. We are happy with the timing of our expansion. And we believe, by then, the world market for electrodes would have grown larger to absorb this 20,000 ton additional electrodes easily adding to our international market shares. The Needle coke availability has substantially eased compared to the recent past due to reduced demand from GE producers and more importantly, an overhang of inventory both with all the electrode producers as well as Needle coke producers as explained above. And accordingly, the pricing of Needle coke are significantly coming down. Our sales in Q3 were at low-50 utilization level, and we expect it to become better from this quarter onwards, as the demand picks up gradually. We do believe that with this new capacity coming on stream, quality of our products will see a marked improvement due to state-of-art equipments and the latest available technology that we are currently in process of installing. This would have a positive impact on the quality of our products. In addition, this will also enable us to do cost savings due to economies of scale and also achieve better efficiencies. With our 4 decades of experience in business, we expect to be a supplier of choice to all our global and Indian customers. With this, I would now hand over the floor to our CFO, Gulshan, to take you through the financial numbers. And then along with our group CFO, Mr. Ajmera, we will be very happy to answer any queries that you may have. Over to you, Mr. Gulshan.

Gulshan Sakhuja

executive
#3

Yes, thank you. For the quarter ended December 2019, HEG recorded revenue from operations of INR 394 crore as against INR 564 crore in the previous quarter and INR 1,865 crores in the corresponding quarter of the last financial year. EBITDA including other income stood at INR 32 cr in quarter 3 versus INR 174 crores of previous year quarter, and INR 1,351 crores in the corresponding quarter of the last financial year. The company reported a net profit of INR 6 crores in quarter 3 as against profit of INR 179 crore in the previous quarter and INR 867 crore in the corresponding quarter of last financial year. The company is debt-free and have been handling our treasury operations to the tune of nearly INR 1,200 crores as on December 31, 2019, and the average return has been around 8% per annum on the same. The company is having a history of maintaining a payout ratio of around 30% to 35%, and we do expect to maintain the same in the current financial year. In line with that, our Board has already approved a payment of interim dividend of 250%, that is 25 per equity share. For the quarter ended December 2013, the company has presented consolidated financial results along with our stand-alone results as a part of the compliance with SEBI circular. The company aims to further strengthen its balance sheet through effective working capital management, thereby creating value for its stakeholders. And now we would now like to address any questions or queries you may have in your mind. Thank you.

Operator

operator
#4

[Operator Instructions] The first question is from the line of Sonali Salgaonkar from Jefferies.

Sonali Salgaonkar

analyst
#5

So my first question is I just wanted to understand what has changed substantially in Q3 versus Q2, which is why we are seeing the results sharply down sequentially as well. And where do you really see the realizations bottoming out?

Manish Gulati

executive
#6

Right. Okay. So if you are asking what has happened between the 2 quarters? There has been less sales. As we said, the Q3 was in the low 50s, and Q2 was in 60s. So that is one reason. And the next reason is a drop in prices or rather adjustment of prices. Coupled with that, we have the Needle coke and our WIPs and finished goods, which were made from the highest price of coke it could get. So -- then the electrodes prices are falling, and we are holding inventory, which is at the earlier raw material prices. So that is what has hit us for Q3.

Sonali Salgaonkar

analyst
#7

Got it. And where -- do you see this as probably the bottom of realizations? Or do you still think that there's still some more pain left?

Manish Gulati

executive
#8

No, I think this should be the bottom. I think so. I hope so, because there is not much room left to go below this -- these levels which you are having. And once we have this high-cost inventory out of our system, the margins should return.

Sonali Salgaonkar

analyst
#9

So by when do you foresee the high cost Needle coke inventory to be out of your system?

Manish Gulati

executive
#10

So let's say, safely take 6 months.

Sonali Salgaonkar

analyst
#11

That's 2 quarters from now?

Manish Gulati

executive
#12

Yes.

Sonali Salgaonkar

analyst
#13

Sir, my second question is, probably you could choose to answer this from an industry level. What is the current level of inventory of graphite electrodes that you see the industry is sitting on? And probably, what time line do you expect to liquidate this?

Manish Gulati

executive
#14

Again, see, people globally, including us, we have adjusted our production levels to reflect the market demand and give time to customers to adjust their energies, which they have. I believe that once people are working on lesser capacity utilizations, not only us, but everybody else, this should now again take 6 months to either liquidate excess inventory that overhang or excess inventory these customers are holding. So we -- probably we have to give everybody a 6-month time frame because, of course, and people have realized that, yes, there's not enough demand in the market. So all the companies have adjusted their capacities to whatever level they could. And again, for the same reason that we have to adjust to the new level and exhaust excess inventories.

Sonali Salgaonkar

analyst
#15

Sure. So my next question is from the perspective of Needle coke. So just wanted to understand probably, what is the current cost of Needle coke? And typically, what is the duration of the contracts? And when is the next renewal up?

Manish Gulati

executive
#16

See, right now, we have excess inventory, then we'll probably know about the Needle levels sometime in March, what kind of -- right now, we are not buying any Needle coke, but we of course have a sense that prices are coming down, probably in the month of March, then we will talk about if -- beyond, we'll have a sense of where the pricing is. So far, the pricing has been 6-monthly at the time. But in the steel conditions, we will see, it all depends on the market. And in good old days, there were -- we used to get into a year-long contract with customers because we used to have year-long back to back contracts for Needle coke. And then the market went hard, it became 6-monthly, then it became 3-monthly. Now we will see in March. I mean, we will see both ways, whether we are willing to get into a 6-month contract, if we don't have enough visibility. Likewise, they can also take a call.

Sonali Salgaonkar

analyst
#17

Sure. And would it be able for you to share what is the current cost of Needle coke?

Manish Gulati

executive
#18

I wouldn't like to say, ma'am, for competitive reasons. But yes, you can. I mean, we have enough data in the market, you can figure out, but I would not like to mention a -- put a figure to that, ma'am.

Sonali Salgaonkar

analyst
#19

I understand, sir. Sir, my next question is related to coronavirus and the probable supply chain disruption in China. Do you see the imports of Chinese graphite electrodes getting affected because of this? Or have you seen or come across any data that they have come down from the start of January to the mid of Feb?

Manish Gulati

executive
#20

See -- I think to be able to properly answer this question, another few days may be required. Because you see before the Chinese went for the holiday, everything was planned and everything was done, organized accordingly. Now it's about a week or 10 days that they are back, and I don't know whether they are back, but maybe another few days, like you and everybody is watching the situation very closely, but I can only share, which is common sense, that if it lasts for a little longer, not only electrodes, several other industries would be impacted. So we should -- I mean we should see some decline in exports, not only in India, because China was exporting a lot of the lower grade, high-power electrodes to several countries in the world. So another few days and it will become clearer actually. Today, I cannot hazard a guess.

Sonali Salgaonkar

analyst
#21

Got it, sir. Sir, could you provide us your current breakup of UHP versus non-UHP and export, export versus domestic?

Manish Gulati

executive
#22

Export versus domestic is about 70%-30%, and UHP versus non-UHP keeps varying a little bit, but if you take an average, it is about 20% to 25%.

Sonali Salgaonkar

analyst
#23

Sorry, what is 22%?

Manish Gulati

executive
#24

20% to 25% is on the portion of our non-UHP platform.

Sonali Salgaonkar

analyst
#25

Non-UHP, I understand, sir. Sir, how are the exports doing in any particular geographies where you are finding constraints or probably a lot of competition because China is exporting in them?

Manish Gulati

executive
#26

No, but China -- the competition, which we have with the China is only for that 20%, 25% of our non-UHP grade, which we make. We do not have straight competition with the Ultra High Power grid, which is our main stake. So I mean this has always been, not only now, they've been -- for the last so many years, we have been competing with this 20%, 25% of our business segment. So it's not restricted to any geography, and that they were exporting this lower grade to so many countries. So we compete with them everywhere.

Sonali Salgaonkar

analyst
#27

Sure. Sir, any particular geographies, which are doing well or not so well export-wise?

Manish Gulati

executive
#28

If you see, I mean, Europe has a lot of slowdown in steel. If you look at the world steel production figure, I can share with you -- it's, let's say, the steel in the Electric Arc Furnace down in Japan, Turkey, South Korea, Russia, Italy, Mexico, Germany. Most of these major steel making countries are down in production. The only place where they seem to be growing is Iran, which is out of our purview. And United States is growing in steel and India is growing in steel. So other than that, the European part is significantly down in production.

Sonali Salgaonkar

analyst
#29

Got it, sir. Sir, are the realizations of export and domestic comparable?

Manish Gulati

executive
#30

Domestic realizations have become much less. The pricing in India has become much too aggressive because it's a home market, and there will be price declines. So -- but in export, it's better, I would say, better than in domestic.

Sonali Salgaonkar

analyst
#31

Would it be able for you to quantify the differential?

Manish Gulati

executive
#32

No, not exactly. But please don't ask for that. Certainly possible -- it's certainly better, I would say.

Sonali Salgaonkar

analyst
#33

Sure. Sir, and my last question, in the opening remarks, you mentioned that there's a 40,000 metric ton shutdown of graphite electrode capacity in Japan. Which player are you referring to?

Manish Gulati

executive
#34

Which -- sorry, which?

Sonali Salgaonkar

analyst
#35

Player? Which company are you referring to?

Manish Gulati

executive
#36

I said in my speech, that this is the largest. But it would not be nice on my part to name all these competitors, but it is very easy for you to find out the largest player. I clearly said in my speech, the largest industry player is from Japan.

Sonali Salgaonkar

analyst
#37

Sure. And when have they shutdown?

Manish Gulati

executive
#38

This news, which we have is about a week old -- a week or 10-day old. Yes. So I think we announced it on 6th of Feb.

Operator

operator
#39

[Operator Instructions] The next question is from the line of Bhavesh Chauhan from IDBI Capital.

Bhavesh Chauhan

analyst
#40

Sir, I just want to know, can you quantify the volume decline that has happened year-over-year or in this quarter?

Manish Gulati

executive
#41

We gave the capacity utilization. As I said, low 50s for this quarter, 60s for Q2 and 70s for Q1, so that's a decline.

Bhavesh Chauhan

analyst
#42

Okay. And sir, when -- in the previous question, you said that the margins are probably at bottom. Or did you mean that pricing of the end products graphite electrodes are at bottom or did you mean the margin?

Manish Gulati

executive
#43

See, the pricing is -- the earlier participant asked about the pricing, and I said that this is about the lowest it can get. And then I added that once new price of raw material kicks in, our margins will improve. And right now, we are still working with that high -- very high cost of Needle coke bought in 2019. And it is just the nature of our industry, which has such a long production cycle of anywhere around 2 to 5 months, and we have books in stock, and it all comes from U.S., Europe and Japan. We always have 2 months first on seaborne transit, which I mentioned in my speech. So it always hits us that way that the electrode prices drop and if you have this kind of inventory already locked and paid for, so that is what caused a hit in margins.

Bhavesh Chauhan

analyst
#44

Yes. And what would be the price differential between UHP and non-UHP today?

Manish Gulati

executive
#45

It's big, actually. It's big, though it's all the time, and the electrodes were short. So both had -- the pricing distance had closed because people wanted electrodes, no matter which grade. But now the pricing is significantly different between the 2.

Operator

operator
#46

[Operator Instructions] The next question is from the line of Sonali Salgaonkar from Jefferies.

Sonali Salgaonkar

analyst
#47

Sir, just one clarification. So the Needle coke that you were using in Q2, that's the earlier quarter, and price that you have in Q3, are they comparable? Or have you seen a sequential rise in Needle coke price as well?

Manish Gulati

executive
#48

No, they are comparable because this always bought this -- these are 2019 contracts. So price of Needle coke we consumed in Q2 and Q3 are almost the same because -- of course, where will the Needle coke come from. This is the price of coke we have been buying since the start of the year. So whatever the price of coke was there with us in Q2, it's the same in Q3 and almost the same and going to be the same in Q4 as well.

Operator

operator
#49

[Operator Instructions] Next question is from the line of [ Ujjwal Agarwal ] from New Horizon.

Unknown Analyst

analyst
#50

This is [ Ujjwal. ] And the question I had is the EBITDA and EBIT margins, if you will, that you were saying for the last 2 years were completely unsustainable, that I understand. But what would be the stable level of EBITDA and EBIT margins that you might be able to see -- that will be sustainable for the long term?

Manish Gulati

executive
#51

I mean, Gulshan, would you like to answer this?

Gulshan Sakhuja

executive
#52

Yes. [ Ujjwal ], you have to see this EBITDA margin is a factor of 2 things. One, that my coke consumption and my selling price. And that means, in the next financial year, they would be going to turn around. That is going to mean to give that effective EBITDA margin. Currently, it's difficult to comment in our next financial year or in terms of future how this EBITDA margin would remain. But if you see the past history, and when that prices were normal, and -- at that time, we were having EBITDA margin in the range of 20% to 25%. But right now, commenting for the future is quite difficult because it is a factor of 2 things. One, that selling price; and the second one is coke.

Unknown Analyst

analyst
#53

Okay. And I have one more question, and it is about the Needle coke price. The Needle coke price -- do you see any extra capacity that might be added to the Needle coke, so that the prices might come down because, as you said before, that it is also used for lithium-ion batteries also. So is there any planned capacity additions all over the world or somewhere that would help us get Needle coke for cheaper?

Manish Gulati

executive
#54

No. You see, the Needle coke prices have already got heated a lot. In fact, they are already in the process of correction. And Needle coke supplies are not even able to use current capacity. So there's no need for -- I mean the new capacity, when they are still grappling with this -- their existing capacity. So the price is already on the way down. We'll get a better feel of these -- the Needle coke prices sometime in March because right now we do not need any Needle coke. So we'll come to know of where the prices settled sometime in March when we talk for coke beyond April.

Operator

operator
#55

[Operator Instructions] The next question is from the line of Santosh Sahu from MC Research.

Anubhav Sahu

analyst
#56

This is Anubhav Sahu. I had couple of questions. One, given that we have a high cost inventory for Needle coke and it probably will take around 2 quarters to consume, so do you think that current margin range of around high single-digit to low double-digit EBITDA margin would sustain for next 2 quarters?

Manish Gulati

executive
#57

No, next 2 quarters should be similar because the Needle coke price is stabilizing. And it's just that how fast we can just get -- can consume our high cost inventory. So I think for the next 2 quarters, situation should be more or less the same. We do not expect anything in ordinate, I mean, whatever is there. I mean -- because we know where we are. We know where electrode prices are today, although they have stabilized, but we know where they are today. We know where we have this -- we have to live with this high cost Needle coke inventory and finished goods inventory we have. So nothing much is expected to change for 2 quarters. However, when -- we definitely are expecting things to get better because the Needle coke prices are coming down, again, to adjust to the market conditions.

Anubhav Sahu

analyst
#58

Sir, I mean, is there a way to check or is there -- do you have an estimate that if we didn't have the high costs inventory, and your input cost for Needle coke in this quarter was, say, at the current prices of Needle coke, which is stable in the market. So then what could have -- what would have been our EBITDA margins or operating margins?

Manish Gulati

executive
#59

Yes. Yes, I think it's a good wish. I keep wishing this all the time. We hope we did not have this inventory because today the electrode prices are of today and the price of coke is of yesterday. So it is causing a mismatch. But I mean, don't -- I wouldn't answer -- I wouldn't be able to answer this question of what EBITDA could have been if we had Needle coke prices of...

Anubhav Sahu

analyst
#60

No, what I mean is that -- I mean the other question would have been like post 2 quarters, what would be the normalized margin you will be looking at? But if there are multiple factors, which would be running, say, after 2 quarters, we wouldn't know, but at present...

Manish Gulati

executive
#61

Yes. For that, you don't even have to ask me. If you look at the electrode industry margins over the last 10 years, that's where it changed, right, 10, 15 years. Just have a look at -- I mean if you have access to it, you have -- not only for us, for others, if you have a look at the industry's margins for the last 10, 15, 20 years, it's a very good indication because that is what is sustainable. That is what led the industry grow at a healthy pace and serve our customers. So that -- I think that is where it should be.

Anubhav Sahu

analyst
#62

Got it. And sir, last question on the industry, per se. I mean any idea of what is the utilization level for the graphite industry right now? I mean is it just close to what we are putting up or it's something different?

Manish Gulati

executive
#63

Some of the players are close to where we are. And some -- one player is probably having a better capacity utilization, which is because they had some -- tied some long-term contracts. Of course, they didn't benefit for the first 2 years. Yes, yes, because they have strong sales, which is already locked up, but -- those legal kind of contracts. So barring those, I think many of us are very similar range today.

Operator

operator
#64

[Operator Instructions] The next question is from the line of [ Payal ] from Ratnamani Investment.

Unknown Analyst

analyst
#65

Sir, my question is on -- yes, yes, sir. Sir my question is related to the inventory. So what is the inventory hit we have taken for the quarter? Is the inventory hit being done, I mean to say, or we can see the -- see it going ahead to hit in some quarter?

Manish Gulati

executive
#66

I rather have Gulshan answer this question. Gulshan?

Gulshan Sakhuja

executive
#67

Payal, can you come again?

Unknown Analyst

analyst
#68

Yes, yes. So I just want to know -- yes. So -- yes. So what is the inventory loss that we have booked in this quarter?

Gulshan Sakhuja

executive
#69

Ma'am, if you see this -- Ma'am, there is no inventory loss. The reduction of this margin is on account of that reduction in the selling prices and that high-cost inventory and the high-cost consumption that we have booked in this quarter. So there is no inventory loss on account of this. But at that front, my EBITDA margin and my EBIT margin have come down on account of that reduction in my selling price and high-cost consumption.

Unknown Analyst

analyst
#70

So consumption that we have...

Gulshan Sakhuja

executive
#71

Yes. Yes.

Unknown Analyst

analyst
#72

So on the remaining Needle coke that we have as a raw material, or WIP, so we have not taken any hit on that, I mean, to say...

Gulshan Sakhuja

executive
#73

And we don't foresee also. And we don't foresee also because taking into consideration that selling price, that is currently prevailing into the market. Basis on that, and we don't foresee, I mean, that inventory is going to come in the books of accounts.

Operator

operator
#74

[Operator Instructions] Members of the management, so would you like to wait for some time? We do not have any questions in the queue as of now.

Manish Gulati

executive
#75

No, no. That's okay.

Gulshan Sakhuja

executive
#76

You can proceed. You can proceed.

Operator

operator
#77

Mr. Gulati, any closing comments?

Manish Gulati

executive
#78

Yes. Thank you, friends, and we are optimistic about the medium- to long-term growth of our industry considering this as a temporary period. And we look forward to speaking to you in the next quarters, hopefully, with more clear picture and a better set of numbers. All the best. Thank you very much. Bye-bye.

Operator

operator
#79

Ladies and gentlemen, on behalf of HEG Limited, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete HEG Limited transcript — plus 251,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to HEG Limited earnings transcripts and 251,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.